Trial intelligence / Profile preview

Growth hormone added to ovulation stimulation in IVF/ICSI for low ovarian reserve

IRCT20130603013566N13Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Jun 2024
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3 trial of somatropin in female infertility and Diminished Ovarian Reserve (DOR), sponsored by Tabriz University of Medical Sciences. Started Jun 2024; status: completed.

02

Drugs

somatropin
03

Conditions

female infertilityDiminished Ovarian Reserve (DOR)

Beyond the preview

Go deeper on IRCT20130603013566N13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20130603013566N13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call